Murillo-Cuesta Silvia, Artuch Rafael, Asensio Fernando, de la Villa Pedro, Dierssen Mara, Enríquez Jose Antonio, Fillat Cristina, Fourcade Stéphane, Ibáñez Borja, Montoliu Lluis, Oliver Eduardo, Pujol Aurora, Salido Eduardo, Vallejo Mario, Varela-Nieto Isabel
Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Instituto de Investigaciones Biomédicas Alberto Sols (IIBM), Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid, Madrid, Spain.
Front Genet. 2020 Oct 14;11:583932. doi: 10.3389/fgene.2020.583932. eCollection 2020.
Animal models are invaluable for biomedical research, especially in the context of rare diseases, which have a very low prevalence and are often complex. Concretely mouse models provide key information on rare disease mechanisms and therapeutic strategies that cannot be obtained by using only alternative methods, and greatly contribute to accelerate the development of new therapeutic options for rare diseases. Despite this, the use of experimental animals remains controversial. The combination of respectful management, ethical laws and transparency regarding animal experimentation contributes to improve society's opinion about biomedical research and positively impacts on research quality, which eventually also benefits patients. Here we present examples of current advances in preclinical research in rare diseases using mouse models, together with our perspective on future directions and challenges.
动物模型对于生物医学研究来说非常宝贵,尤其是在罕见病的研究背景下,因为罕见病发病率极低且往往情况复杂。具体而言,小鼠模型提供了关于罕见病机制和治疗策略的关键信息,而这些信息仅通过其他方法无法获得,并且极大地有助于加速罕见病新治疗方案的开发。尽管如此,实验动物的使用仍然存在争议。对动物实验进行尊重管理、遵循伦理法律以及保持透明度,有助于改善社会对生物医学研究的看法,并对研究质量产生积极影响,最终也会使患者受益。在此,我们展示了利用小鼠模型进行罕见病临床前研究的当前进展实例,以及我们对未来方向和挑战的看法。